MLR isn’t about replacing people with AI.It’s about defining where oversight, control, and judgment are critical across the workflow. Co-authored with experts from Alexion, Takeda, and Indegene, this whitepaper lays out a practical human–AI model for compliant, scalable review. Read the full report ➡️ https://lnkd.in/ghTWHjY4
Indegene
Business Consulting and Services
Princeton, New Jersey 599,559 followers
Strategic operating partner to the life sciences industry
About us
Indegene is the strategic operating partner to the life sciences industry, orchestrating commercial, medical, R&D, and safety operations across the product lifecycle. Trusted by the world’s top 20 biopharma companies, Indegene helps run complex, highly regulated workflows at global scale. Indegene combines deep life sciences expertise with AI-embedded platforms and governed operating models to improve speed, consistency, and compliance across mission-critical operations. By integrating technology into how work is executed and scaled, Indegene enables life sciences organizations to deliver measurable outcomes in regulated environments.
- Website
-
https://www.indegene.com/
External link for Indegene
- Industry
- Business Consulting and Services
- Company size
- 5,001-10,000 employees
- Headquarters
- Princeton, New Jersey
- Type
- Public Company
- Founded
- 1998
- Specialties
- Analytics, Technology, Operations, Medical Affairs, Multichannel Marketing, Regulatory Affairs, Creative Solutions, Pharmacovigilance, Drug Safety, Pharma Branding, Medical Devices, Medical Communication, Medical Information Management, Pharma Marketing, and Promotional Literature Review
Locations
Employees at Indegene
Updates
-
Most healthcare ML models never make it to production. Uncover how to xix the gap with MLOps—automate, scale, and turn models into real-world impact in this whitepaper. Read the full report ➡️ https://lnkd.in/g9-ZgA5j
-
-
In today’s digital ecosystem, even the strongest scientific content must be engaging, concise, and platform-adapted to capture attention. Publication extenders bridge the gap between scientific depth and digital engagement, enabling brand teams to deliver high-performing, audience-centric content. Learn how to maximize the value of your scientific content ➡️ https://lnkd.in/g9pYCAUw
-
-
Valid HCP data forms the backbone of effective engagement, enabling seamless audience orchestration across channels, reinforcing compliance, and unlocking measurable outcomes. Discover how life sciences organizations can build reliable, future-ready HCP data ecosystems to support more effective omnichannel strategies. Read the full report ➡️ https://lnkd.in/gciC7pHQ
-
-
If your team is managing thousands of label updates, notifications, and proof cycles, the issue isn’t workload, it’s workflow. A centralized, regionally intelligent labeling model can turn compliance from a bottleneck into an engine. Explore how this was achieved across a 250+ product portfolio in APAC. Read the case study ➡️ https://lnkd.in/g-zASxA9
-
-
How do life sciences organizations move from fragmented data to a truly data-driven enterprise? We designed and deployed a structured Data & Analytics Excellence Maturity Assessment Framework to help benchmark capabilities, uncover gaps, and drive measurable transformation across Commercial and Medical functions. Read the case study to know how data strategy turns into real capability uplift ➡️ https://lnkd.in/guZ7Z59P
-
-
𝐈𝐧𝐝𝐞𝐠𝐞𝐧𝐞 - 𝐓𝐡𝐞 𝐀𝐈-𝐃𝐫𝐢𝐯𝐞𝐧 𝐆𝐫𝐨𝐰𝐭𝐡 𝐎𝐮𝐭𝐥𝐢𝐞𝐫 Our CFO, Suhas Prabhu, spoke with Shivam Tyagi from The Economic Times - ETCFO about the AI-driven shift reshaping the life sciences industry, how AI is reinforcing Indegene’s differentiation across commercial and medical operations, and why disciplined, technology-led growth remains central to how we create long-term value. The conversation also covers our approach to scaling AI-led capabilities, expanding strategic partnerships, and evaluating growth opportunities in key global markets. What does thoughtful AI adoption look like in life sciences today? Suhas shares his perspective. Read more ➡️ https://lnkd.in/gcU2ggJw
-
-
The future of MLR review is not just faster workflows. It’s intelligent orchestration powered by AI, human expertise, and scalable governance. This latest whitepaper by Robert Liebman explores how life sciences organizations can move beyond incremental automation to build AI-enabled, human-in-the-loop MLR models that improve speed, consistency, compliance, and reviewer experience at scale. Read the full report ➡️ https://lnkd.in/gk5VkdQX
-
-
Indegene has been featured by Salesforce for scaling the Agentforce Life Sciences ecosystem, across both SI and Content partner categories! Being among a select group represented across both categories is a reflection of the work our teams have built in operationalizing AI across commercial, medical, and customer engagement workflows in life sciences, at real scale. As organizations rethink engagement and content delivery models, the ability to implement AI responsibly, compliantly, and at scale will matter more than ever. Congratulations to the teams driving innovation and execution across the Salesforce ecosystem! Read more from Salesforce here ➡️ https://lnkd.in/gxGT-fs6
-
-
We’ve wrapped up the Pharmaceutical Management Science Association (PMSA) Annual Conference 2026! Thank you to everyone who participated and contributed throughout the discussions 😊 Across the sessions, there was a great exchange of ideas, thoughtful conversations, and valuable collaboration. A special thank you to Punit Kumar, Ashok Vardhan, and Indegene team Ashish Sharma, Ravi Shankar, Shekhar Gupta, Karthikeyan Krishnakumar Looking forward to building on the momentum and insights from these conversations
-